⭐️ CURE ⭐️
Recruiting now
Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China
A large trial testing blinatumomab and venetoclax to improve survival and reduce side effects in children with intermediate/high-risk B-cell ALL.
Read lead report →
⭐️ CURE ⭐️
Completed
Phase: PHASE1 • Sponsor: University of Pennsylvania
A Phase I trial testing a gene therapy injection for vision loss caused by RPE65 mutations, aiming to restore sight in Leber congenital amaurosis.
Read report →
⭐️ CURE ⭐️
Not yet recruiting
Phase: PHASE2 • Sponsor: Prince of Wales Hospital, Shatin, Hong Kong
A phase 2 trial testing whether a one-time gene therapy called HGI-001 can free people with transfusion-dependent β-thalassemia from needing regular blood trans
Read report →
⭐️ CURE ⭐️
Not yet recruiting
Phase: PHASE3 • Sponsor: Kringle Pharma, Inc.
A phase 3 trial testing whether an injected drug, KP-100IT, can help people with severe spinal cord injuries regain movement and sensation.
Read report →
⭐️ CURE ⭐️
Completed
Phase: PHASE2 • Sponsor: Brii Biosciences Limited
A phase 2 trial testing whether a combination of two experimental drugs can clear chronic hepatitis B infection and allow patients to stop standard therapy.
Read report →
⭐️ CURE ⭐️
ENROLLING_BY_INVITATION
Sponsor: N.N. Alexandrov National Cancer Centre
A trial testing whether anti-CD19 CAR-T cell therapy can induce remission in patients with refractory systemic lupus erythematosus.
Read report →
⭐️ CURE ⭐️
Recruiting now
Phase: PHASE2 • Sponsor: Lexeo Therapeutics
A phase 2 trial testing whether a single dose of LX2006 gene therapy can improve heart function in people with Friedreich ataxia cardiomyopathy.
Read report →
⭐️ CURE ⭐️
Recruiting now
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota
A phase I/II trial testing bortezomib plus CPX-351 in newly diagnosed TP53-mutated acute myeloid leukemia, aiming to improve response and survival.
Read report →
⭐️ CURE ⭐️
Not yet recruiting
Phase: PHASE2 • Sponsor: Medical University of South Carolina
A trial testing whether adding cemiplimab to chemotherapy before surgery can eliminate early-stage non-small cell lung cancer tumors.
Read report →
⭐️ CURE ⭐️
Recruiting now
Phase: PHASE1 • Sponsor: Sichuan University
A phase 1 trial testing DLL3-targeted CAR-T cells with PD-L1/4-1BB modification for relapsed small cell lung cancer.
Read report →